Finance

Lists
Why is DTCFF up 5.54%?
Dive Deeper
DTCFF:OTCMKTS
Defence Therapeutics Inc
$0.18
+5.54%
(+0.0097) 1D
Nov 19, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DTCFF...
Open
$0.18
High
$0.18
Low
$0.18
Mkt. cap
18.95M
Avg. vol.
14.34K
Volume
200.00
52-wk high
$0.76
52-wk low
$0.17
Beta
2.37
Shares outstanding
76.11M
Open
$0.18
High
$0.18
Low
$0.18
Mkt. cap
18.95M
Avg. vol.
14.34K
Volume
200.00
52-wk high
$0.76
52-wk low
$0.17
Beta
2.37
Shares outstanding
76.11M
News stories
From web sources and news partners
About Defence Therapeutics Inc
CEO-
Employees-
Founded2017
HeadquartersVancouver, British Columbia, Canada
SectorHealth Care
IndustryBiotechnology
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
115.60K
316.51K
729.19K
280.05K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
353.71K
964.46K
401.52K
1.63M
Operating expense
599.46K
1.37M
1.16M
2.57M
Total operating expenses
599.46K
1.37M
1.16M
2.57M
Operating income
-599.46K
-1.37M
-1.16M
-2.57M
Other non operating income
-75.71K
-36.17K
-1.75M
1.15M
EBT including unusual items
-703.00K
-1.52M
-2.96M
-1.59M
EBT excluding unusual items
-703.00K
-1.52M
-2.96M
-1.59M
Income tax expense
-
-
-
-86.88K
Effective tax rate
-
-
-
5.48%
Other operating expenses
-
-
-
-
Net income
-703.00K
-1.52M
-2.96M
-1.50M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
631.00
-
2.27K
Interest expense
-11.92K
-111.06K
-76.49K
-142.67K
Net interest expenses
-11.92K
-110.43K
-76.49K
-140.40K
Depreciation and amortization charges
16.24K
9.28K
9.42K
37.17K
EBITDA
-589.88K
-1.36M
-1.15M
-2.53M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps